INT251889

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.07
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

RNA binding (Naf1) nucleus (Naf1) ribosome biogenesis (Naf1)
cytoplasm (Naf1)
Anatomy Link Frequency
plasma 1
Naf1 (Mus musculus)
Pain Link Frequency Relevance Heat
COX-2 inhibitor 2 53.84 Quite High
cINOD 8 5.00 Very Low Very Low Very Low
peptic ulcer disease 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Breast Cancer 36 40.24 Quite Low
Incontinence 2 14.80 Low Low
Dysgeusia 2 14.12 Low Low
Exanthema 2 13.52 Low Low
Vomiting 4 13.28 Low Low
Diarrhoea 4 12.96 Low Low
Heart Rate Under Development 4 8.40 Low Low
Pressure And Volume Under Development 2 6.48 Low Low
Cancer 44 5.00 Very Low Very Low Very Low
Metastasis 12 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We first evaluated the change in uPA, PAI-1 and PGE2 concentration in the NAF of each participant after low and high dose celecoxib administration (Table 2).
Regulation (change) of NAF
1) Confidence 0.07 Published 2008 Journal BMC Cancer Section Body Doc Link PMC2580770 Disease Relevance 0 Pain Relevance 0
Considering subjects in both dosage groups, there was an inverse correlation between celecoxib concentration and change in NAF PGE2 (r = -.42, p = .06, n = 20) and plasma uPA (r = .38, p = .012, n = 42) post treatment, which was not observed for the other markers.
Regulation (change) of NAF in plasma
2) Confidence 0.04 Published 2008 Journal BMC Cancer Section Body Doc Link PMC2580770 Disease Relevance 0 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox